(Q27022482)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

1 reference

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Alberto Ocana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Eitan Amir

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

11

Ian F Tannock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1

Arnoud J Templeton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

3

Boštjan Šeruga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Francisco Vera-Badillo

4

object named as

Francisco E Vera-Badillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

5

Priya Aneja

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

7

Raya Leibowitz-Amit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Guru Sonpavde

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jennifer J Knox

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ben Tran

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

1 reference

29 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

19 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

106

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

dju124

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

Immunity, Inflammation, and Cancer

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Inflammation-based prognostic indices in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophils in the antitumoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Activated human neutrophils release hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Cytokine patterns in patients with cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Characteristics of the serum pepsinogen (Pg) test, and the relationship between Pg test results and gastric cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Generation of Biologically Active Angiostatin Kringle 1-3 by Activated Human Neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU124

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJU124

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24875653%20AND%20SRC:MED&resulttype=core&format=json